Market opportunities lie in enhancing risk-based V&V planning, focusing on DQ, IQ, OQ, and PQs to address cGMP deficiencies and regulatory expectations. By aligning with FDA, ICH, and ISO standards, ...

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...

Bioanalytical method development and validation are at the forefront of ensuring rigorous, reproducible and reliable data in both drug development and clinical diagnostics. The field encompasses the ...

Seemant Sehgal is Founder & CEO of BreachLock Inc., a leader in Continuous Attack Surface Discovery & Penetration Testing as a Service. Offensive security strategies are now a top business priority ...